Have your own idea? Try our Stock Screener
Hong Kong (HSI) Drug Retail Industry Analysis
UpdatedJul 31, 2026
DataAggregated Company Financials
Companies6
- 7D3.8%
- 3M-16.7%
- 1Y-26.8%
- YTDn/a
The Drug Retail industry is up 3.8% in the last week, with JD Health International up 6.5%. During this same period, the Lung Fung Group Holdings underperformed, falling 9.6%. In contrast, the industry has lost 27% in the last 12 months. Earnings are forecast to grow by 15% annually.
Industry Valuation and Performance
Has the Hong Kong Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 01 Aug 2026 | HK$201.7b | HK$143.5b | HK$8.7b | 31.4x | 23.1x | 1.4x |
| Mon, 29 Jun 2026 | HK$168.8b | HK$142.6b | HK$8.7b | 27.1x | 19.4x | 1.2x |
| Wed, 27 May 2026 | HK$211.2b | HK$142.7b | HK$8.7b | 36x | 24.3x | 1.5x |
| Fri, 24 Apr 2026 | HK$251.5b | HK$140.3b | HK$8.6b | 45.4x | 29.2x | 1.8x |
| Sun, 22 Mar 2026 | HK$266.0b | HK$140.3b | HK$7.8b | 87.9x | 34.3x | 1.9x |
| Tue, 17 Feb 2026 | HK$331.0b | HK$129.4b | HK$6.9b | 45.7x | 47.8x | 2.6x |
| Thu, 15 Jan 2026 | HK$397.8b | HK$127.9b | HK$6.8b | 58.3x | 58.1x | 3.1x |
| Sat, 13 Dec 2025 | HK$313.8b | HK$126.2b | HK$6.8b | 40.4x | 46.4x | 2.5x |
| Mon, 10 Nov 2025 | HK$316.8b | HK$122.2b | HK$6.1b | 57.8x | 51.6x | 2.6x |
| Wed, 08 Oct 2025 | HK$360.5b | HK$122.4b | HK$6.2b | 67x | 58.6x | 2.9x |
| Fri, 05 Sep 2025 | HK$369.1b | HK$122.3b | HK$6.1b | 66.8x | 60x | 3x |
| Sun, 03 Aug 2025 | HK$269.7b | HK$114.8b | HK$4.5b | 49.8x | 60.1x | 2.3x |
| Tue, 01 Jul 2025 | HK$242.0b | HK$115.6b | HK$4.5b | 48.7x | 53.6x | 2.1x |
| Thu, 29 May 2025 | HK$230.4b | HK$115.0b | HK$4.5b | 47.5x | 51.3x | 2x |
| Sat, 26 Apr 2025 | HK$214.7b | HK$109.9b | HK$4.1b | 58.2x | 51.8x | 2x |
| Mon, 24 Mar 2025 | HK$213.5b | HK$110.7b | HK$4.2b | 62.9x | 51.1x | 1.9x |
| Wed, 19 Feb 2025 | HK$230.5b | HK$103.8b | HK$3.6b | 56.7x | 64.1x | 2.2x |
| Fri, 17 Jan 2025 | HK$154.8b | HK$103.2b | HK$3.6b | 36.9x | 43.3x | 1.5x |
| Sun, 15 Dec 2024 | HK$166.6b | HK$103.9b | HK$3.6b | 39.6x | 46.3x | 1.6x |
| Tue, 12 Nov 2024 | HK$180.9b | HK$103.5b | HK$3.3b | 52.7x | 55.1x | 1.7x |
| Thu, 10 Oct 2024 | HK$179.8b | HK$105.4b | HK$3.3b | 51.5x | 53.8x | 1.7x |
| Sat, 07 Sep 2024 | HK$137.2b | HK$105.4b | HK$3.3b | 37x | 41x | 1.3x |
| Mon, 05 Aug 2024 | HK$135.9b | HK$103.4b | HK$2.4b | 40.7x | 56.1x | 1.3x |
| Wed, 03 Jul 2024 | HK$135.5b | HK$101.9b | HK$2.4b | 40.8x | 56.8x | 1.3x |
| Fri, 31 May 2024 | HK$163.4b | HK$102.5b | HK$2.4b | 48.8x | 68.1x | 1.6x |
| Sun, 28 Apr 2024 | HK$150.8b | HK$103.7b | HK$2.3b | 45.2x | 64.8x | 1.5x |
| Tue, 26 Mar 2024 | HK$162.4b | HK$103.8b | HK$13.8m | 48.5x | 11807.2x | 1.6x |
| Thu, 22 Feb 2024 | HK$174.4b | HK$105.1b | -HK$1,456,710,874.59 | 57.6x | -119.7x | 1.7x |
| Sat, 20 Jan 2024 | HK$165.0b | HK$106.2b | -HK$1,472,017,604.00 | 52.5x | -112.1x | 1.6x |
| Mon, 18 Dec 2023 | HK$210.6b | HK$106.0b | -HK$1,468,328,668.00 | 65.8x | -143.4x | 2x |
| Wed, 15 Nov 2023 | HK$216.5b | HK$102.0b | -HK$1,739,012,940.00 | 90.1x | -124.5x | 2.1x |
| Fri, 13 Oct 2023 | HK$232.7b | HK$102.4b | -HK$1,676,016,734.00 | 107.7x | -138.9x | 2.3x |
| Sun, 10 Sep 2023 | HK$227.3b | HK$102.0b | -HK$1,669,943,661.00 | 84.1x | -136.1x | 2.2x |
| Tue, 08 Aug 2023 | HK$283.0b | HK$96.0b | -HK$4,166,873,266.00 | 130.3x | -67.9x | 2.9x |
Price to Earnings Ratio
-67.9x
Current Industry PE
- Investors are pessimistic on the Hong Kong Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 23.1x which is lower than its 3-year average PE of 99x.
- The 3-year average PS ratio of 1.9x is higher than the industry's current PS ratio of 1.4x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 14% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Hong Kong Drug Retail compare with similar industries?
| HK Market | 2.13% | |
| Consumer Staples | 7.01% | |
| Food and Staples Retail | 4.50% | |
| Drug Retail | 3.80% | |
| Food Retail | 7.00% | |
| Food Distributors | -1.50% | |
| Big Box Super Stores | -2.62% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6618 JD Health International | HK$39.40 | 6.5% +HK$7.7b | -19.2% | PE20.1x | |
| 241 Alibaba Health Information Technology | HK$3.59 | 7.5% +HK$4.0b | -25.5% | PE25.8x | |
| 1833 Ping An Healthcare and Technology | HK$7.82 | 6.0% +HK$935.7m | -34.8% | PE37.7x | |
| 314 Sipai Health Technology | HK$1.32 | 1.5% +HK$14.6m | -78.0% | PS0.4x |